Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

US: Archimed completes take private of Esperion

Buy Out Nick Herbert -
France-based global healthcare investor has completed the take private of Esperion Therapeutics, a US-based, commercial-stage biopharmaceutical company bringing innovative cardiometabolic and rare/orphan disease therapies to market. The transaction is valued at up to approximately US$1.1bn in total equity value on a fully diluted basis, assuming full achievement of certain...

Asset-light pharma services enter new era: insight from the IIH Private Capital Conference

Analysis Nick Herbert -
Asset-light pharma services are entering a new era as pharmaceutical companies grapple with increasingly complex regulatory, commercial and technological challenges. Although growth in pharma commercialisation has slowed sharply from pre-pandemic levels, panellists at the Asset-light pharma service presentation at Investors in Healthcare’s Private Capital Conference in June argued that improving biotech funding, a growing pipeline of drug launches, rising pharmaceutical spending and continued outsourcing are creating renewed opportunities for specialist service providers. Private equity investors continue to be attracted to the sector, but the characteristics of the most appealing businesses...